Had the shareholder group contact with Kev and discussed with him the proposals ?
And if yes: How was his reaction ?
Lack of transparency was always an allegation against BoD. Would be great if you @boy1, @Ubique13 or the rest of the crew could share this and other requested information with all shareholders.
@Gwaihir
Good to read another perspective. For me Kev and his willingness to remain MD is also the key question.
Appreciate your further research
- Forums
- ASX - By Stock
- FFX
- Ann: Notice Received Under Section 249D of the Corporations Act
Ann: Notice Received Under Section 249D of the Corporations Act, page-101
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online